Sodium danshensu attenuates cerebral ischemia–reperfusion injury by targeting AKT1

The beneficial properties of Sodium Danshensu (SDSS) for controlling cerebral ischemia and reperfusion injury (CIRI) are elucidated here both in vivo and in vitro. SDSS administration significantly improved the viability of P12 cells, reduced lactate dehydrogenase (LDH) leakage, and decreased the ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Qing, Deng, Hao, Yang, Zhengfei, Yang, Qiuyue, Zhang, Yilin, Yuan, Xiaopeng, Zeng, Miao, Guo, Maojuan, Zeng, Wenyun, Jiang, Xijuan, Yu, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520076/
https://www.ncbi.nlm.nih.gov/pubmed/36188542
http://dx.doi.org/10.3389/fphar.2022.946668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520076/
https://www.ncbi.nlm.nih.gov/pubmed/36188542
http://dx.doi.org/10.3389/fphar.2022.946668

Ejemplares similares